What Are the Cons and Risks of Donating Eggs?

Egg donation carries a real set of medical, emotional, and practical downsides that every prospective donor should understand before signing on. The most common physical risk is ovarian hyperstimulation syndrome (OHSS), which affects the majority of donors to some degree, and the most underappreciated risk may be the near-total absence of long-term follow-up data. The process also demands weeks of hormone injections, multiple clinic visits, and an invasive retrieval procedure under sedation, all of which come with their own complications and disruptions.

What Ovarian Hyperstimulation Actually Feels Like

The hormones used to stimulate your ovaries into producing multiple eggs at once can cause your ovaries to swell and leak fluid into the abdomen. This is OHSS, and it exists on a spectrum. In a survey of 289 egg donors reporting on 801 donation cycles, only about 20% of cycles produced no OHSS symptoms at all. Roughly 45% resulted in mild symptoms, which are considered a normal response to stimulation and might include bloating, mild pelvic discomfort, and nausea. About a quarter of cycles led to moderate OHSS, and around 9% resulted in severe symptoms. A small fraction, about 0.5% of cycles, produced critical OHSS requiring urgent medical attention.¹

Severe and critical OHSS can mean significant abdominal pain, vomiting, difficulty breathing due to fluid accumulation in the chest, and in rare cases, kidney problems or blood clots. The good news is that the type of “trigger” medication used to finalize egg maturation makes a real difference. Donors whose cycles used a GnRH agonist trigger reported significantly milder symptoms compared to those who received the older hCG trigger or a combination of both.¹ In a large study of over 4,000 donor cycles using hCG triggering, moderate-to-severe OHSS occurred in under 1% of cycles, and about half of those cases required hospitalization.² The discrepancy between that figure and the self-reported rates above likely reflects differences in how OHSS is measured: clinician-diagnosed rates tend to be lower than what donors themselves report experiencing.

If you are considering donation, it is worth asking your clinic which trigger protocol they use. Clinics that have moved toward GnRH agonist triggers are offering a genuinely safer experience on this front.

Risks During and After the Retrieval Procedure

The egg retrieval itself is a minor surgical procedure. A needle guided by ultrasound passes through the vaginal wall into each ovary to aspirate the follicles containing eggs. You are typically sedated for this, and the whole thing takes around 20 to 30 minutes. Most donors recover within a day or two, but complications, while uncommon, do happen.

In a prospective study of over 1,000 retrievals, vaginal bleeding occurred in about 2.8% of procedures. In that series, no cases of internal abdominal bleeding were recorded, and pelvic infection did not occur, though one case of unexplained fever was noted.³ A separate review of 1,000 donor cases found a 0.7% rate of serious complications, which included severe OHSS, adverse reactions to intravenous anesthesia, internal bleeding, and bladder problems.⁴ Another study of 886 retrieval cycles reported the same 0.7% serious complication rate, with cases including OHSS, ovarian torsion (where the ovary twists on itself), infection, and a ruptured ovarian cyst.⁵

Infection is rare but can be severe when it does occur. A case report documented a 30-year-old woman who developed serious intra-abdominal sepsis after egg retrieval, with the infection centered in the area behind the uterus where the retrieval needle passes. The authors emphasized that physicians need to maintain a high level of suspicion for this complication, because early treatment is critical.⁶

Blood clots are another rare but documented risk. Deep vein thrombosis has been reported in connection with ovarian hyperstimulation, and the hormonal changes associated with the stimulation cycle contribute to a temporarily increased clotting tendency.⁷

The Long-Term Health Unknown

This is where the conversation shifts from documented risks to a more uncomfortable reality: nobody can tell you with confidence what egg donation does to your body decades later. The research simply has not been done. As one group of researchers put it bluntly, the lack of long-term follow-up studies means that egg donors’ long-term health risks are unknown, and the absence of information should not be mistaken for the absence of risk.⁸

The specific concern that comes up most often is cancer, particularly breast and ovarian cancer. High-dose hormonal stimulation temporarily floods the body with estrogen levels far above the normal range. Long-term hormone replacement therapy is recognized as a breast cancer risk factor, and while ovarian stimulation involves much shorter exposure, the intensity is much higher, and donors are typically in their twenties, a period when breast tissue may be more sensitive to hormonal influence. The honest answer is that current data cannot confirm or rule out an increased cancer risk from egg donation. What researchers have called for is mandatory longitudinal registries that track donors over time, but no country has systematically implemented this.⁸

There are also unresolved questions about whether repeated stimulation cycles could affect future fertility, ovarian reserve, or the timing of menopause. These worries are plausible given the biology, but the evidence base is thin. The fertility field has been criticized for the gap between the growing number of donors worldwide and the near-total lack of standardized follow-up mechanisms to track what happens to them.

How Repeat Donation Compounds the Uncertainty

Many donors donate more than once. The financial incentive is significant, and agencies often recruit previous donors specifically because they have a proven track record. But each additional cycle means another round of hormonal stimulation and another retrieval procedure. The American Society for Reproductive Medicine has acknowledged that existing data do not allow for firm recommendations on the number of cycles a donor should undergo, while noting that safety and well-being concerns warrant caution.⁹

One practical finding from donor self-reports is that if your first cycle gives you significant OHSS, your second cycle is likely to as well. OHSS severity in a donor’s second cycle was strongly associated with their experience in the first.¹ This is useful information if you are considering whether to go back for another cycle: a rough first experience is not a fluke that will resolve next time. It is probably predictive.

Emotional and Psychological Risks

The physical side gets most of the attention, but egg donation is also psychologically complex in ways that can catch donors off guard. A systematic review found that donors face psychosocial challenges across multiple dimensions: short-term reactions to the treatment itself (stress, discomfort, disruption to daily life), emotional responses to the role of being a donor, and longer-term feelings about any children conceived from their eggs.¹⁰

The question of offspring contact is one that many donors do not fully think through at the time of donation. In countries where donors can choose between anonymous and identity-release donation, their feelings about potential future contact vary widely. Among identity-release donors who voluntarily registered, the vast majority expressed positive or neutral feelings about the possibility of being contacted by donor-conceived children. But about 5% said they would prefer not to be contacted at all, and that reluctance was somewhat higher among donors who had donated years earlier.¹¹ On the other side, donors who chose anonymous donation often actively hoped they would not be traced by offspring.¹²

The emotional landscape shifts over time. A 25-year-old donating eggs to help pay for graduate school may feel very differently about the existence of genetic offspring when she is 40 with her own family. Direct-to-consumer DNA testing has made true anonymity increasingly impossible regardless of what the contract says. Donors who assumed they would never be identified are now being found through genetic databases, which can create emotional situations nobody anticipated at the time of donation.

Even the screening process itself can cause harm. Prospective donors who go through the extensive medical and psychological evaluation but are ultimately rejected report negative emotional effects including disappointment, fear, anger, and sadness. For most, those feelings are temporary, but for some, they are more lasting and seriously upsetting.¹³

Gaps in Informed Consent

One of the more troubling findings in the egg donation literature is that many donors do not feel they were adequately informed before they went through the process. In a survey of egg donors, about two-thirds felt their overall experience matched what they had been told to expect. But when asked specifically about long-term risks, over 55% said they did not feel well informed. About 10% reported not being informed about OHSS at all, and another 21% said they received only partial information about the range of possible OHSS outcomes.¹⁴

This is a structural problem, not just an individual clinic failing. When long-term data barely exist, clinics face an awkward position: they cannot inform donors about risks that have not been studied. But the failure to communicate that uncertainty itself, to say clearly “we do not know what this does to you in 20 years,” is its own form of inadequate consent. Researchers have flagged that informed consent in egg donation often falls short because it presents the absence of evidence as reassurance rather than as an open question.⁸

The Time and Physical Burden of a Cycle

Beyond the medical risks, the practical burden of a donation cycle is something that sounds manageable in a brochure and feels heavier in practice. A typical cycle involves two to four weeks of self-administered hormone injections, usually one to three shots per day. During this time, you will need frequent monitoring appointments at the clinic for blood draws and transvaginal ultrasounds to track how your ovaries are responding. These visits often need to happen early in the morning and may be required every day or every other day as retrieval approaches.

For anyone with a rigid work schedule, classes, or caregiving responsibilities, fitting these appointments in can be genuinely disruptive. Travel may be required if the clinic is not local. Physical side effects during the stimulation phase commonly include bloating, mood swings, headaches, breast tenderness, and fatigue. After retrieval, most donors are told to rest for a day or two, but some experience discomfort for a week or longer, particularly if OHSS develops. The process is not a quick in-and-out procedure, and underestimating the time commitment is one of the most common regrets donors report.

How Regulations Vary Around the World

The risks of egg donation are shaped not just by biology but by the legal and commercial framework in which it happens. The United States is one of the few countries where eggs can be bought and sold on the open market, with compensation to donors sometimes reaching tens of thousands of dollars. Agencies openly advertise in college newspapers, and compensation can scale with traits like academic achievement. In contrast, EU countries prohibit commercial egg sales, permitting only reimbursement for basic expenses like travel and time off work.¹⁴

Different countries also impose different limits on how many children can be born from a single donor’s eggs. In the U.S., the ASRM guideline suggests no more than 25 births per donor within a population of 800,000, primarily to reduce the chance of half-siblings unknowingly forming relationships. Spain caps it at six children per donor, and Hong Kong allows no more than three pregnancies from one donor’s gametes.¹⁴

The commercial nature of egg donation in certain countries raises specific exploitation concerns. Cross-border reproductive care, where patients travel from wealthier countries to obtain eggs in places where they are cheaper and more readily available, can put financial pressure on donors in economically vulnerable situations. Researchers have noted that financial compensation holds strong appeal for donors in lower-income settings, and that donors in these contexts often lack adequate awareness of the medical risks, sometimes donating multiple times under conditions where information about those risks is incomplete.¹⁴

Anesthesia and Sedation Considerations

The egg retrieval is performed under sedation, typically conscious sedation or light general anesthesia. While anesthesia-related complications are uncommon in young, healthy women, they are not zero. Adverse reactions to intravenous anesthesia have been documented among the serious complications in donor cycles.⁴ A review of anesthetic approaches for egg retrieval found that evidence of serious toxicity in humans is not well established, and that different anesthetic techniques have not been clearly distinguished in terms of outcomes. Some studies have suggested that general anesthesia might be associated with lower pregnancy rates in the recipients, though others have not confirmed that finding. Lighter sedation and regional anesthesia appear to be safe alternatives.¹⁵ For donors specifically, the question of anesthetic safety is mostly about your own comfort and risk during the procedure rather than any downstream effect on embryos, since you are not the one getting pregnant.

What You Can Do to Reduce Your Risk

If you decide to move forward with egg donation, there are concrete steps you can take to minimize the downsides. Ask the clinic about their OHSS rates and whether they use GnRH agonist triggers, which are associated with milder hyperstimulation. Ask about their serious complication rate and what protocols they have for managing OHSS if it develops. Find out how many cycles they recommend per donor and whether they have any follow-up program after donation is complete.

Pay close attention during the informed consent process. If the clinic presents the long-term risks as negligible or nonexistent, push back: the evidence does not support that level of confidence, and a clinic that acknowledges what is unknown is being more honest than one that glosses over it. Consider how you feel about the possibility that a person genetically related to you may exist in the world and may someday try to contact you. That is not a hypothetical you can defer thinking about indefinitely.

Keep your own medical records from the process. Note the medications you were given, the doses, the number of eggs retrieved, and any symptoms you experienced. No centralized registry is tracking this for you, and if future research does establish connections between ovarian stimulation and later health outcomes, having your own records could matter for your care.